CASI Pharmaceuticals, Inc. (CASI): Stock Price

CASI Pharmaceuticals (CASI) business is constrained by stringent FDA and NMPA oversight, high development costs, and antibody patent protection. This market valuation on GURU.Markets confirms the asset's current value, which stands at 0.21. Growth is driven by EVOMELA supplies, CID-103 trials, and the expansion of Western innovations into Asia. Stable cash flow is guaranteed by exclusive sales rights in China and resilient demand.

Market Chart: CASI Pharmaceuticals (CASI) for 07/04/2022 - 03/14/2026

Metric breakdowns and analytics for CASI Pharmaceuticals, Inc (CASI)

- stock quotes and analyst forecast:

Stock Price CASI Pharmaceuticals|CASI - Consensus Target

- stock exchange capitalization data:

Market Capitalization CASI Pharmaceuticals Inc.|CASI - Enterprise Value

- book capitalization information:

Net Assets per Single Share CASI Pharmaceuticals|CASI - Book Valuation of Business|Market Capitalization to Book Value Ratio casipharmaceuticals.com|CASI - Company Total Asset Base

- company liabilities and liquidity data:

Total Debt to Capital CASI Pharmaceuticals|CASI - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital CASI Pharmaceuticals|CASI - Company Aggregate Debts|Debt to Book Capitalization Ratio CASI Pharmaceuticals Inc.|CASI - Company Long-Term Indebtedness|Company Short-Term Debts CASI Pharmaceuticals|Quick Ratio casipharmaceuticals.com

- company profitability and valuation multiples indicators:

CASI - Company Net Income|Expected Profit CASI Pharmaceuticals|CASI - Company Value to Net Income|Projected Price to Earnings CASI Pharmaceuticals|CASI - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple CASI Pharmaceuticals Inc.|CASI - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months CASI Pharmaceuticals|CASI - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months casipharmaceuticals.com|CASI - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year CASI Pharmaceuticals

Comprehensive company analysis:CASI CASI Pharmaceuticals, Inc.

Retaining leading experts in oncohematology and expanding clinical trials between China and the US create the foundation for the capitalization of CASI Pharmaceuticals (CASI). Analyzing asset dynamics on the exchange, an investor sees the market value of the security, which reflects liquidity inflows and market expectations, allowing for an assessment of the balance between real value growth and the risk of a speculative bubble forming.

CASI Pharmaceuticals, Inc. (CASI): Stock Price

Metric breakdowns and analytics for CASI Pharmaceuticals, Inc (CASI)

Who CASI Pharmaceuticals competes with